US Patent Issued to Regeneron Pharmaceuticals on April 14 for "Anti-New York esophageal squamous cell carcinoma 1 (NY-ESO-1) antigen-binding proteins and methods of use thereof" (New York Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,783, issued on April 14, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Anti-New York esophageal squamous cell carcinoma 1 (NY-ESO-1) antigen-binding proteins and methods of use thereof" was invented by Kevin A. Bray (Tarrytown, N.Y.), Frank Delfino (Tarrytown, N.Y.), David Dilillo (Tarrytown, N.Y.), Matthew C. Franklin (Tarrytown, N.Y.), Jessica Kirshner (Tarrytown, N.Y.) and Douglas MacDonald (Tarrytown, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides antigen-binding proteins that specifically bind to an H LA-displayed New York esophageal squamous cell carcinoma 1 (NY-ESO-1) peptide, and the...